The consumer healthcare group is aiming to close the site on a phased basis over the next two years.
Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reuters on Tuesday. "Following a strategic review of our global manufacturing capabilities, we have determined that our Maidenhead site is no longer a viable option for the manufacture of our products," the spokesperson said. The making of toothpastes will be transferred to Haleon's hub in Slovakia, while mouthwash production will be moved to a third party contract manufacturer, details of which have yet to be announced.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...